CD19 CAR-T Expressing IL7 and CCL19: 2 Clinical Trials

Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma

Condition(s):Diffuse Large B-cell Lymphoma; Mantle Cell Lymphoma; Transformed Follicular Lymphoma; Primary Mediastinal Large B-cell LymphomaLast Updated:April 6, 2021Completed

CD19 CAR-T Expressing IL7 and CCL19 Combined With PD1 mAb for Relapsed or Refractory Diffuse Large B Cell Lymphoma

Condition(s):Diffuse Large B-cell LymphomaLast Updated:June 29, 2020Recruiting

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.